Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 41 days ago
Share
A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
90 patients around the world
Available in
Spain, Chile, Brazil, United States
Celgene
90
Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Follicular lymphoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
GOLSEEK-2
Sponsor
Celgene
Conditions
Follicular lymphoma
Requirements
From 18 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06425302
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent